Docket #: S02-234
Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells
Please see issued patent and publication, below, for details.
Publications
Patents
- Published Application: 20050176142
Similar Technologies
-
Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity S22-458Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity
-
SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy S17-501SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy
-
A method to increase the anti-tumor activity of immune cells via inhibition or genetic disruption of the mediator complex S20-341A method to increase the anti-tumor activity of immune cells via inhibition or genetic disruption of the mediator complex